Biotech

FDA
MedTech

FDA approves Humacyte’s off-the-shelf artery for trauma repairs

Humacyte’s tissue-based Symvess is designed to be universally implantable for patients facing the loss of a limb.
Conor Hale Dec 23, 2024 10:36am
MA

Ikena, after tough year of layoffs, merges with Inmagene

Dec 23, 2024 10:00am
Hybrid FSPFSO Solutions Keep Biotech Trials on Time and on Budget

Hybrid FSP/FSO Solutions Keep Biotech Trials on Time and on Budget

Nov 1, 2024 8:00am
compass map direction find trail north

Rapt pays $35M for challenger to Novartis, Roche drug

Dec 23, 2024 8:10am
video
Carl Sailer on AI market trends and strategic planning in biotech

Carl Sailer on AI, market trends, and strategic planning in biotech

Oct 28, 2024 8:00pm
Sanofi

Sanofi pays SK $52M as children's pneumococcal shot enters ph. 3

Dec 23, 2024 8:05am